Postdoc and Alumni News
This space is reserved to all postdoctoral fellows from MD Anderson Cancer Center post news about themselves, such as awards they get, new techniques they develop, a paper they publish, or other accomplishments, like a promotion or a new job position. Our goal with this space is to develop network among postdocs. For example, if you want to apply for a grant, you can check if a postdoc at MD Anderson Cancer Center got it and ask him/her for help preparing your application…
Email us your news! firstname.lastname@example.org
Dr. Ann Bailey is currently a member of the Clinical Decision Support Team of IPCT at MD Anderson. The IPCT is a research program that has set its mission on personalizing cancer therapy for MD Anderson patients by using tumor biomarkers, namely next generation sequencing of tumor DNA, to help guide patient therapy options. Her role on this team is to assist MD Anderson clinical oncologists in interpreting tumor sequencing data and provide information on potential therapy options based on tumor genomic alterations. The information gathered on cancer genes and their implications in cancer therapy populates the publically shared content on www.personalizedcancertherapy.org. In addition, the IPCT provides this clinical support via molecular tumor boards, clinical trial planning meetings, and individual patient reports. The overall goal of the IPCT is to augment the overwhelmingly daunting task facing oncologists assessing potential therapy options of thousands of possible genomic alterations in over a hundred actionable cancer genes.
Dr. Jaymie L. Estrella was a Postdoctoral Fellow in the Department of Lymphoma/Myeloma. In collaboration with several industrial companies she investigated the cellular mechanisms of newly developed anti-cancer drugs using in vitro cell line models of lymphoma disease. In February 2013 she accepted a position at TEVA Pharmaceuticals as the Oncology Medical Science Liaison for the Southern California/Arizona territory. At TEVA her role is to build relations with key opinion leaders and to communicate the latest news in TEVA branded products with the oncology medical community.
Dr. Wendy Tai was an Odyssey Fellow in the department of Experimental Pediatrics. In August 2012 she accepted a position as oncology regional medical liaison (RML) for Celgene Corporations. As a Celgene representative, her role as the TX and LA RML is to built rapport with key opinion leaders and initiate and coordinate clinical trials with the oncology research community.
Dr. Tiffany Doucette finished her postdoc in December 2011 and was promoted to Instructor in the Dept. of Neurosurgery at MD Anderson Cancer Center in the laboratory of Dr. Ganesh Rao.
Dr. Melissa Thompson finished her postdoctoral fellowship in August 2012 at MD Anderson Cancer Center and began a new position as the Program Director for the Gulf Coast Consortia (GCC). In this position, she works closely with faculty, executives and administrators to manage multidisciplinary inter-institutional research among the six member institutions of the GCC (BCM, UTMB, MDACC, UTHSC, Rice, and UH).